Literature DB >> 31446501

Echocardiographic assessment of mitral regurgitation.

Nobuyuki Kagiyama1, Sirish Shrestha2.   

Abstract

Mitral regurgitation (MR) is one of the most frequent indications for valve surgery in developed countries, and echocardiographic assessment is an essential tool to evaluate its etiologies, severity, and therapeutic indications. The mitral valve apparatus is a complex structure composed of several parts: apart from the mitral valve leaflets and annulus, it also includes the chordae tendineae, papillary muscles, and left ventricular (LV) wall. MR can be caused not only by organic changes of the mitral valve leaflets or chordae (primary MR) but also by extreme mitral annular enlargement or mitral leaflet tethering due to displacement and malfunction of papillary muscles and LV wall (secondary MR). In secondary MR with LV dysfunction, a milder degree of MR can be associated with adverse outcomes compared with primary MR. Grading the severity is the first step in evaluation of indication for surgical/transcatheter interventions. As such, there are several techniques to assess the severity of MR using echocardiography. However, none of the techniques is reliable enough by itself, and it is always recommended to integrate multiple methods. In cases where echocardiographic assessment of MR severity is inconclusive, magnetic resonance may be helpful. In addition to the severity, anatomical information, such as localization in primary MR due to mitral valve prolapse and LV size in secondary MR due to LV dilatation/dysfunction, is an important concern in presurgical echocardiography. Transesophageal echocardiography and three-dimensional echocardiography are key techniques for anatomical evaluation including mitral valve and LV volumes. In transcatheter intervention for MR, echocardiography plays a pivotal role as a guide for procedures and endpoints. In this review article, the authors provide a comprehensive summary of current standards of echocardiographic assessment of MR.

Entities:  

Keywords:  Echocardiography; Mitral regurgitation; Mitral valve prolapse; Mitral valve repair; Three-dimensional (3D) echocardiography; Transcatheter mitral valve repair

Mesh:

Year:  2019        PMID: 31446501     DOI: 10.1007/s10396-019-00971-1

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  58 in total

1.  The significance of late systolic murmurs and mid-late systolic clicks.

Authors:  J B BARLOW; W A POCOCK
Journal:  Md State Med J       Date:  1963-02

2.  Characterization of degenerative mitral valve disease using morphologic analysis of real-time three-dimensional echocardiographic images: objective insight into complexity and planning of mitral valve repair.

Authors:  Sonal Chandra; Ivan S Salgo; Lissa Sugeng; Lynn Weinert; Wendy Tsang; Masaaki Takeuchi; Kirk T Spencer; Anne O'Connor; Michael Cardinale; Scott Settlemier; Victor Mor-Avi; Roberto M Lang
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-30       Impact factor: 7.792

3.  The value of three-dimensional echocardiography derived mitral valve parametric maps and the role of experience in the diagnosis of pathology.

Authors:  Wendy Tsang; Lynn Weinert; Lissa Sugeng; Sonal Chandra; Homaa Ahmad; Kirk Spencer; Victor Mor-Avi; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2011-06-29       Impact factor: 5.251

4.  Strain Echocardiography and Functional Capacity in Asymptomatic Primary Mitral Regurgitation With Preserved Ejection Fraction.

Authors:  Amgad Mentias; Peyman Naji; A Marc Gillinov; L Leonardo Rodriguez; Grant Reed; Tomislav Mihaljevic; Rakesh M Suri; Joseph F Sabik; Lars G Svensson; Richard A Grimm; Brian P Griffin; Milind Y Desai
Journal:  J Am Coll Cardiol       Date:  2016-08-31       Impact factor: 24.094

5.  Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation.

Authors:  Julien Magne; Patrizio Lancellotti; Luc A Piérard
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

6.  Value and limitations of proximal jet dimensions for the quantitation of valvular regurgitation: an in vitro study using Doppler flow imaging.

Authors:  H Baumgartner; H Schima; P Kühn
Journal:  J Am Soc Echocardiogr       Date:  1991 Jan-Feb       Impact factor: 5.251

7.  Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation.

Authors:  Jean-François Obadia; David Messika-Zeitoun; Guillaume Leurent; Bernard Iung; Guillaume Bonnet; Nicolas Piriou; Thierry Lefèvre; Christophe Piot; Frédéric Rouleau; Didier Carrié; Mohammed Nejjari; Patrick Ohlmann; Florence Leclercq; Christophe Saint Etienne; Emmanuel Teiger; Lionel Leroux; Nicole Karam; Nicolas Michel; Martine Gilard; Erwan Donal; Jean-Noël Trochu; Bertrand Cormier; Xavier Armoiry; Florent Boutitie; Delphine Maucort-Boulch; Cécile Barnel; Géraldine Samson; Patrice Guerin; Alec Vahanian; Nathan Mewton
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

8.  Doppler color flow mapping in the diagnosis of ventricular septal rupture and acute mitral regurgitation after myocardial infarction.

Authors:  J H Smyllie; G R Sutherland; R Geuskens; K Dawkins; N Conway; J R Roelandt
Journal:  J Am Coll Cardiol       Date:  1990-05       Impact factor: 24.094

9.  Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007.

Authors:  Vinay Badhwar; Eric D Peterson; Jeffrey P Jacobs; Xia He; J Matthew Brennan; Sean M O'Brien; Rachel S Dokholyan; Kristopher M George; Steven F Bolling; David M Shahian; Fredrick L Grover; Fred H Edwards; James S Gammie
Journal:  Ann Thorac Surg       Date:  2012-08-02       Impact factor: 4.330

10.  The Course of Ischemic Mitral Regurgitation in Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention: From Emergency Room to Long-Term Follow-Up.

Authors:  Shun Nishino; Nozomi Watanabe; Toshiyuki Kimura; Maurice Enriquez-Sarano; Tatsuya Nakama; Makoto Furugen; Hiroshi Koiwaya; Keiichi Ashikaga; Nehiro Kuriyama; Yoshisato Shibata
Journal:  Circ Cardiovasc Imaging       Date:  2016-08       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.